Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 14, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 19 November 2025 - 10:30

Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 14, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/shingrix

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters